A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
for Advanced Pancreatic Carcinoma
109 locations incl. Birmingham
Sponsor: Sameek Roychowdhury
Sex: All·Age: 18+
Code: NCT06906562·Phase 2·Recruiting